For Industry

Generic Drug Regulatory Science Initiatives Public Meeting: June 21, 2013

The Food and Drug Administration (FDA or the Agency) has scheduled a public meeting on June 21, 2013 to discuss generic drug regulatory science initiatives designed to promote the public health and advance innovation in regulatory decision-making.  The meeting will provide a forum for public discussion of Agency generic drug research priorities and an overview of current efforts.  FDA is seeking input from a variety of stakeholders––industry, academia, patient advocates, professional societies, and others as it develops its annual FY 2014 regulatory science plan.   Additional information on the public meeting is available at:

Page Last Updated: 03/10/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English